Table 10.

Summary of Recommendations

Recommendations	Evidence (According to GRADE [21, 22])
The annual use of CgA, PP, and glucagon as a tumor marker for the diagnosis of NF-pNETs is not recommended.	(1|⊕⊕⊕○)
Radiological screening for NF-pNET should include MRI or endoscopic ultrasonography.	(2|⊕⊕○○)
68Ga-DOTA PET/CT should be preferred over 111In single photon emission CT/CT for the diagnosis of NF-pNETs.	(1|⊕⊕○○)
68Ga-DOTA PET/CT should not be routinely used for the diagnosis of NF-pNETs.	(2|⊕○○○)
Based on the growth rate and NF-pNET size, pancreatic visualization can be extended to once per 1 to 2 y.	(2|⊕⊕○○)
Screening for NF-pNETs in asymptomatic MEN1 patients should not be extended until the age of 16.	(2|⊕○○○)

Abbreviation: GRADE, Grading of Recommendations, Assessment, Development, and Evaluation.